Colistin in burn intensive care: Back to the future?

Burns

Volumn 39, Issue 1, 2013, Pages 7-15

  Azzopardi, Ernest A ^a,b   Boyce, Dean E ^b   Thomas, David W ^a   Dickson, William A ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Colistin; Literature trends; Redevelopment

Indexed keywords

COLISTIMETHATE; COLISTIN; LIPOPOLYSACCHARIDE; NEOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BURN; CLINICAL RESEARCH; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG STRUCTURE; HUMAN; HYDROLYSIS; HYDROPHOBICITY; INTENSIVE CARE; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; REVIEW; STRUCTURE ACTIVITY RELATION; SYSTEMATIC REVIEW;

ANTI-BACTERIAL AGENTS; BURNS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS;

EID: 84872049177     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2012.07.015     Document Type: Review

References (119)

1. L. Rice Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE The Journal of Infectious Diseases 197 2008 1079 1081
2. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, and L.B. Rice Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 12
3. J.S. Hawley, C.K. Murray, M.E. Griffith, M.L. McElmeel, L.C. Fulcher, and D.R. Hospenthal Susceptibility of Acinetobacter strains isolated from deployed US military personnel Antimicrob Agents Chemother 51 2007 376 378
4. D.N. Herndon, and M. Spies Modern burn care 2001 p. 28
5. H. Giamarellou, and G. Poulakou Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 69 2009 1879 1901
6. C. Morel, and E. Mossialos Stoking the antibiotic pipeline BMJ 340 2010 c2115
7. Azzopardi EA. Characterising aetiology, incidence and specific risk factors for Gram-negative burn wound infection: a structured, evidence-based review. Unpublished Thesis. Cardiff: Cardiff University; 2009.
8. J. Conly, and B. Johnston Colistin: the phoenix arises Can J Infect Dis Med Microbiol 17 2006 267 269
9. R.L. Nation, and J. Li Optimizing use of colistin and polymyxin B in the critically ill 1994-2007 Thieme Medical Publishers New York p. 604-14
10. D.P. Healy, A.D. Sombun, J.C. Gardner, K. Good, P.J. Durkee, and L. Toner Pharmacokinetics of colistin in an adolescent boy with extensive burn injury Journal of Burn Care & Research 32 2011 e7
11. J. Li, R.L. Nation, J.D. Turnidge, R.W. Milne, K. Coulthard, and C.R. Rayner Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections Lancet Infect Dis 6 2006 589 601
12. T. Suzuki, and K. Fujikawa Studies on the chemical structure of colistin. IV. Chemical structure of colistin B J Biochem 56 1964 182 189
13. T. Suzuki, K. Hayashi, and K. Fujikawa Studies on the chemical structure of colistin. III. Enzymatic hydrolysis of colistin A J Biochem 54 1963 412 418
14. T. Suzuki, H. Inouye, K. Fujikawa, and S. Nagasawa Studies on the chemical structure of colistin. II. Amino acid sequence of colistin A J Biochem 54 1963 173 180
15. T. Suzuki, H. Inouye, K. Fujikawa, and Y. Suketa Studies on the chemical structure of colistin. 1. Fractionation molecular weight determination, amino acid and fatty acid structure J Biochem 54 1963 25 33
16. C. Govaerts, E. Adams, A. Van Schepdael, and J. Hoogmartens Hyphenation of liquid chromatography to ion trap mass spectrometry to identify minor components in polypeptide antibiotics Anal Bioanal Chem 377 2003 909 921
17. I. Elverdam, P. Larsen, and E. Lund Isolation and characterization of three new polymyxins in polymyxins B and E by high-performance liquid chromatography J Chromatogr 218 1981 653 661
18. Y. Ikai, H. Oka, J. Hayakawa, N. Kawamura, T. Mayumi, and M. Suzuki Total structures of colistin minor components J Antibiot 51 1998 492 498
19. J.A. Orwa, C. Govaerts, K. Gevers, E. Roets, A. Van Schepdael, and J. Hoogmartens Study of the stability of polymyxins B1, E1 and E2 in aqueous solution using liquid chromatography and mass spectrometry J Pharm Biomed Anal 29 2002 203 212
20. J.A. Orwa, C. Govaerts, K. Gevers, E. Roets, A. Van Schepdael, and J. Hoogmartens Study of the stability of polymyxins B(1), E(1) and E(2) in aqueous solution using liquid chromatography and mass spectrometry J Pharm Biomed Anal 29 2002 203 212
21. D. Decolin, P. Leroy, A. Nicolas, and P. Archimbault Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues J Chromatogr Sci 35 1997 557 564
22. T. Kline, D. Holub, J. Therrien, T. Leung, and D. Ryckman Synthesis and characterization of the colistin peptide polymyxin E1 and related antimicrobial peptides J Pept Res 57 2001 175 187
23. T. Velkov, P.E. Thompson, and R.L. Nation Structure-activity relationships of polymyxin antibiotics J Med Chem 53 5 2009 1898 1916
24. A. Rustici, M. Velucchi, R. Faggioni, M. Sironi, P. Ghezzi, and S. Quataert Molecular mapping and detoxification of the lipid A binding site by synthetic peptides Science 259 1993 361
25. J. Meredith, A. Dufour, and M. Bruch Comparison of the structure and dynamics of the antibiotic peptide polymyxin B and the inactive nonapeptide in aqueous trifluoroethanol by NMR spectroscopy J Phys Chem B 113 2009 544 551
26. P. Pristovsek, and J. Kidric Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study J Med Chem 42 1999 4604 4613
27. P. Pristovsek, and J. Kidric The search for molecular determinants of LPS inhibition by proteins and peptides Curr Top Med Chem 4 2004 1185 1201
28. A. Clausell, M. Garcia-Subirats, M. Pujol, M. Busquets, F. Rabanal, and Y. Cajal Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides J Phys Chem B 111 2007 551 563
29. M. Melo, R. Ferre, and M. Castanho Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations Nat Rev Microbiol 7 2009 245 250
30. J. Powers, and R. Hancock The relationship between peptide structure and antibacterial activity Peptides 24 2003 1681 1691
31. R.E. Hancock Antibacterial peptides and the outer membranes of gram-negative bacilli J Med Microbiol 46 1997 1 3
32. R.E. Hancock, and R. Lehrer Cationic peptides: a new source of antibiotics Trends Biotechnol 16 1998 82 88
33. A. Clausell, F. Rabanal, M. Garcia-Subirats, M. Alsina, and Y. Cajal Membrane association and contact formation by a synthetic analogue of polymyxin B and its fluorescent derivatives J Phys Chem B 110 2006 4465 4471
34. V.M. Bhor, C.J. Thomas, N. Surolia, and A. Surolia Polymyxin B: an ode to an old antidote for endotoxic shock Mol Biosyst 1 2005 213 222
35. R. Jerala, and M. Porro Endotoxin neutralizing peptides Curr Top Med Chem 4 2004 1173 1184
36. R.M. Gabrielson Colistin sulfate and sodium colistimethate JAMA 214 1970 763
37. N.J. Goodwin Colistin sulfate versus sodium colistimethate Ann Intern Med 70 1969 232 233
38. S.J. Wallace, J. Li, R.L. Nation, C.R. Rayner, D. Taylor, and D. Middleton Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens Antimicrob Agents Chemother 52 3 2008 1159 1161
39. A.C. Gales, R.N. Jones, and H.S. Sader Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09) J Antimicrob Chemother 66 9 2011 2070 2074
40. D.E. Karageorgopoulos, and M.E. Falagas Current control and treatment of multidrug-resistant Acinetobacter baumannii infections Lancet Infect Dis 8 2008 751 762
41. M. Sinirtas, H. Akalin, and S. Gedikoglu Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance Int J Infect Dis 13 2009 e217 e220
42. M. Dizbay, A. Altuncekic, B.E. Sezer, K. Ozdemir, and D. Arman Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia Int J Antimicrob Agents 32 2008 29 32
43. D. Diekema, M. Pfaller, F. Schmitz, J. Smayevsky, J. Bell, and R. Jones Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999 Clin Infect Dis 32 2001 S114
44. A.C. Gales, R.N. Jones, J. Turnidge, R. Rennie, and R. Ramphal Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999 Clin Infect Dis 32 2001 S146 S155
45. A.C. Gales, A.O. Reis, and R.N. Jones Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines J Clin Microbiol 39 2001 183
46. A.C. Gales, A.O. Reis, and R.N. Jones Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines J Clin Microbiol 39 2001 183 190
47. 2+ environments J Bacteriol 179 1997 7040
48. R.S. Conrad, and C. Galanos Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance Antimicrob Agents Chemother 33 1989 1724
49. M. Vaara, and T. Vaara Polycations as outer membrane-disorganizing agents Antimicrob Agents Chemother 24 1983 114
50. T.I. Nicas, and R. Hancock Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin J Bacteriol 143 1980 872
51. M. Brown, P. Collier, and P. Gilbert Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies Antimicrob Agents Chemother 34 1990 1623
52. M.D. Adams, G.C. Nickel, S. Bajaksouzian, H. Lavender, A.R. Murthy, and M.R. Jacobs Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system Antimicrob Agents Chemother 53 2009 3628 3634
53. W. Fu, F. Yang, X. Kang, X. Zhang, Y. Li, and B. Xia First structure of the polymyxin resistance proteins Biochem Biophys Res Commun 361 2007 1033 1037
54. D.M. Sabuda, K. Laupland, J. Pitout, B. Dalton, H. Rabin, and T. Louie Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa Can J Infect Dis Med Microbiol 19 2008 413 418
55. J.T. Oh, Y. Cajal, E.M. Skowronska, S. Belkin, J. Chen, and T.K. Van Dyk Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli Biochim Biophys Acta 1463 2000 43 54
56. X.Z. Li, L. Zhang, and K. Poole Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa J Antimicrob Chemother 45 2000 433
57. M. Germ, E. Yoshihara, H. Yoneyama, and T. Nakae Interplay between the efflux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa Biochem Biophys Res Commun 261 1999 452 455
58. T.Y. Tan, and S.Y. Ng The in vitro activity of colistin in gram-negative bacteria Singapore Med J 47 2006 621 624
59. K.S. Ko, J.Y. Suh, K.T. Kwon, S.-I. Jung, K.-H. Park, and C.I. Kang High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea J Antimicrob Chemother 60 2007 1163 1167
60. A. Antoniadou, F. Kontopidou, G. Poulakou, E. Koratzanis, I. Galani, and E. Papadomichelakis Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster J Antimicrob Chemother 59 2007 786 790
61. J. Gilad, S. Eskira, K. Riesenberg, F. Schlaeffer, E. Hyam, and A. Borer Emergence of nosocomial colistin-resistant Acinetobacter baumannii Program and Abstracts of the 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Washington, DC 2005 American Society for Microbiology Washington, DC 333
62. J.M. Andrews Determination of minimum inhibitory concentrations J Antimicrob Chemother 48 2001 5
63. J.M. Andrews Chapter 2: determination of minimum inhibitory concentrations 2006 British Society for Antimicrobial Therapy
64. I. Galani, F. Kontopidou, M. Souli, P.D. Rekatsina, E. Koratzanis, and J. Deliolanis Colistin susceptibility testing by Etest and disk diffusion methods Int J Antimicrob Agents 31 2008 434 439
65. J.M. Andrews BSAC methods for antimicrobial susceptibility testing. Version 10 2011 p. 2011
66. J.R. Lo-Ten-Foe, A.M. de Smet, B.M. Diederen, J.A. Kluytmans, and P.H. van Keulen Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains Antimicrob Agents Chemother 51 2007 3726 3730
67. I.M. van der Heijden, A.S. Levin, E.H. De Pedri, L. Fung, F. Rossi, and G. Duboc Comparison of disc diffusion. Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins Ann Clin Microbiol Antimicrob 6 2007 8
68. L.A. Arroyo, A. Garcia-Curiel, M.E. Pachon-Ibanez, A.C. Llanos, M. Ruiz, and J. Pachon Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii J Clin Microbiol 43 2005 903 905
69. M. Barnett, S.R. Bushby, and S. Wilkinson Sodium sulphomethyl derivatives of polymyxins Br J Pharmacol Chemother 23 1964 552 574
70. E. Beveridge, and A. Martin Sodium sulphomethyl derivatives of polymyxins Br J Pharmacol Chemother 29 1967 125
71. D.J. Gmur, C.R. Bredl, S.J. Steele, S. Cai, D.R. VanDevanter, and P.A. Nardella Determination of polymyxin E1 in rat plasma by high-performance liquid chromatography J Chromatogr B Analyt Technol Biomed Life Sci 789 2003 365 372
72. J. Li, R.W. Milne, R.L. Nation, J.D. Turnidge, T.C. Smeaton, and K. Coulthard Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration Antimicrob Agents Chemother 47 2003 1766
73. J. Li, R.W. Milne, R.L. Nation, J.D. Turnidge, and K. Coulthard Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography Antimicrob Agents Chemother 47 2003 1364 1370
74. H. Wunsch, V.K. Moitra, M. Patel, and A.L. Dzierba Polymyxin use associated with respiratory arrest Chest 141 2012 515 517
75. A. Poudyal, B.P. Howden, J.M. Bell, W. Gao, R.J. Owen, and J.D. Turnidge In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae J Antimicrob Chemother 62 2008 1311
76. T.Y. Tan, L.S.Y. Ng, E. Tan, and G. Huang In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates J Antimicrob Chemother 60 2007 421
77. R.J. Owen, J. Li, R.L. Nation, and D. Spelman In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates J Antimicrob Chemother 59 2007 473 477
78. N. Markou, H. Apostolakos, C. Koumoudiou, M. Athanasiou, A. Koutsoukou, and I. Alamanos Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients Crit Care 7 2003 R78 R83
79. A. Michalopoulos, S.K. Kasiakou, E.S. Rosmarakis, and M.E. Falagas Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin Scand J Infect Dis 37 2005 142 145
80. D. Plachouras, M. Karvanen, L.E. Friberg, E. Papadomichelakis, A. Antoniadou, and I. Tsangaris Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria Antimicrob Agents Chemother 53 2009 3430 3436
81. M.J. Rogers, and J. Cohen Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium Infection 14 1986 79 81
82. B. Davies, and J. Cohen Endotoxin removal devices for the treatment of sepsis and septic shock Lancet Infect Dis 11 2011 65 71
83. 97Ru-transferrin uptake in tumor and abscess Eur J Nucl Med Mol Imaging 8 1983 491 494
84. P. Laverman, O.C. Boerman, W.J. Oyen, E.T. Dams, G. Storm, and F.H. Corstens Liposomes for scintigraphic detection of infection and inflammation Adv Drug Deliv Rev 37 1999 225 235
85. P. Laverman, O.C. Boerman, W.J.G. Oyen, F.H.M. Corstens, and G. Storm In vivo applications of PEG liposomes: unexpected observations Crit Rev Ther Drug Carrier Syst 18 2001 551 566
86. P. Laverman, E.T. Dams, G. Storm, T.G. Hafmans, H.J. Croes, and W.J. Oyen Microscopic localization of PEG-liposomes in a rat model of focal infection J Control Release 75 2001 347 355
87. H.J. Rennen, J. Makarewicz, W.J. Oyen, P. Laverman, F.H. Corstens, and O.C. Boerman The effect of molecular weight on nonspecific accumulation of (99m)T-labeled proteins in inflammatory foci Nucl Med Biol 28 2001 401 408
88. C. Sikkink, M. Reijnen, P. Laverman, W. Oyen, and H. van Goor Tc-99m-PEG-liposomes target both adhesions and abscesses and their reduction by hyaluronate in rats with fecal peritonitis J Surg Res 154 2009 246 251
89. P.G. Stansly, R.G. Shepherd, and H.J. White Polymyxin: a new chemotherapeutic agent Bull Johns Hopkins Hosp 81 1947 43 54
90. C.M. Kunin, and A. Bugg Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body J Infect Dis 124 1971 394
91. C.M. Kunin, W.A. Craig, M. Kornguth, and R. Monson Influence of binding on the pharmacologic activity of antibiotics Ann NY Acad Sci 226 1973 214 224
92. P.D. Hoeprich The polymyxins Med Clin N Am 54 1970 1257
93. B. Newton The properties and mode of action of the polymyxins Microbiol Mol Biol Rev 20 1956 14
94. M. Ledson, M. Gallagher, C. Cowperthwaite, R. Convery, and M. Walshaw Four years' experience of intravenous colomycin in an adult cystic fibrosis unit Eur Respir J 12 1998 592 594
95. K.J. Ryan, L.I. Schainuck, R.O. Hickman, and G.E. Striker Colistimethate toxicity J Am Med Assoc 207 1969 2099
96. R.E. Randall, G.S. Bridli, J.G. Setter, and N.C. Brackett Recovery from colistimethate nephrotoxicity Ann Intern Med 73 1970 491
97. S.K. Moestrup, S. Cui, H. Vorum, C. Bregengård, S. Bjørn, and K. Norris Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs J Clin Invest 96 1995 1404
98. M. Vaara, J. Fox, G. Loidl, O. Siikanen, J. Apajalahti, and F. Hansen Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents Antimicrob Agents Chemother 52 2008 3229 3236
99. J. Berg, C. Spilker, and S. Lewis Effects of polymyxin B on mammalian urinary bladder J Membr Biol 154 1996 119 130
100. M. Rosanova, C. Epelbaum, A. Noman, M. Villasboas, V. Alvarez, and G. Berberian Use of colistin in a pediatric burn unit in Argentina J Burn Care Res 30 2009 612
101. J.P. Zhang, X.S. Yang, J. Chen, Y.Z. Peng, and Y.S. Huang Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn Zhonghua Shao Shang Za Zhi 25 2009 372 376
102. L.K. Branski, A. Al-Mousawi, H. Rivero, M.G. Jeschke, A.P. Sanford, and D.N. Herndon Emerging infections in burns Surg Infect (Larchmt) 10 2009 389 397
103. J. Goverman, J.M. Weber, T.J. Keaney, and R.L. Sheridan Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population J Burn Care Res 28 2007 421
104. H. Ganapathy, S.K. Pal, L. Teare, and P. Dziewulski Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit Burns 36 4 2009 522 527
105. J. Zhang, X. Yang, J. Chen, Y. Peng, and Y. Huang Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn Zhonghua Shao Shang Za Zhi Chinese Journal of Burns 25 2009 372
106. M.D. David, and M.J. Gill Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin J Antimicrob Chemother 61 2008 962 964
107. M.E. Falagas, and P.I. Rafailidis Nephrotoxicity of colistin: new insight into an old antibiotic Clin Infect Dis 48 2009 1729 1731
108. M.E. Falagas, and S.K. Kasiakou Toxicity of polymyxins: a systematic review of the evidence from old and recent studies Crit Care 10 2006 R27
109. K. Nakajima Structure-activity relationship of colistins Chemical & Pharmaceutical Bulletin 15 1967 1219
110. Z. Ma, J. Wang, R.L. Nation, J. Li, J.D. Turnidge, and K. Coulthard Renal disposition of colistin in the isolated perfused rat kidney Antimicrob Agents Chemother 53 2009 2857 2864
111. J. Weinstein, A. Afonso, E. Moss Jr., and G.H. Miller Selective chemical modifications of polymyxin B Bioorg Med Chem Lett 8 1998 3391 3396
112. B.R. Srinivasa, and L.K. Ramachandran Essential amino groups of polymyxin B Indian J Biochem Biophys 17 1980 112 118
113. B.R. Srinivasa, and L.K. Ramachandran Chemical modification of peptide antibiotics: part VII - biological activity of derivatives of polymyxin B Indian J Biochem Biophys 15 1978 54 58
114. N.M. Witzke, and H. Heding Broad-spectrum derivatives of polymyxin B and colistin J Antibiot (Tokyo) 29 1976 1349 1350
115. 14C)-derivatives of the membrane-specific polypeptide antibiotic polymyxin B Z Naturf B 25 1970 117
116. T. Kurihara, H. Takeda, and H. Ito Studies on the compounds related to colistin. V. Synthesis and pharmacological activity of colistin analogues Yakugaku Zasshi 92 1972 129 134
117. K. Kanazawa, Y. Sato, K. Ohki, K. Okimura, Y. Uchida, and M. Shindo Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity Chem Pharm Bull (Tokyo) 57 2009 240 244
118. E. Azzopardi, E. Ferguson, and D. Thomas Polymer therapeutics for effective antimicrobial targeting in burn injury (Abstract) Br J Surg 98 2011 S2
119. V. Trottier, P.G. Segura, N. Namias, D. King, L.R. Pizano, and C.I. Schulman Outcomes of Acinetobacter baumannii infection in critically ill burned patients J Burn Care Res 28 2007 248